Invesco Nasdaq Biotechnology ETF to Issue Dividend of $0.03 (NASDAQ:IBBQ)

Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) announced a dividend on Friday, June 19th, NASDAQ Dividends reports. Stockholders of record on Monday, June 22nd will be paid a dividend of 0.0342 per share on Friday, June 26th. The ex-dividend date is Monday, June 22nd.

Invesco Nasdaq Biotechnology ETF Price Performance

NASDAQ IBBQ opened at $29.98 on Friday. Invesco Nasdaq Biotechnology ETF has a 52-week low of $20.67 and a 52-week high of $30.50. The business’s 50-day moving average price is $29.49 and its 200 day moving average price is $29.14. The firm has a market cap of $67.75 million, a P/E ratio of 17.03 and a beta of 0.62.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently modified their holdings of the stock. Osaic Holdings Inc. lifted its stake in shares of Invesco Nasdaq Biotechnology ETF by 28.4% in the 2nd quarter. Osaic Holdings Inc. now owns 4,757 shares of the company’s stock worth $101,000 after acquiring an additional 1,052 shares during the period. Ascentis Independent Advisors acquired a new position in shares of Invesco Nasdaq Biotechnology ETF during the first quarter worth about $31,000. Royal Bank of Canada purchased a new position in Invesco Nasdaq Biotechnology ETF during the fourth quarter worth about $37,000. International Assets Investment Management LLC purchased a new position in Invesco Nasdaq Biotechnology ETF during the fourth quarter worth about $41,000. Finally, Advisory Services Network LLC acquired a new stake in Invesco Nasdaq Biotechnology ETF in the third quarter valued at about $52,000.

About Invesco Nasdaq Biotechnology ETF

The Invesco Nasdaq Biotechnology ETF (IBBQ) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index, a modified market-cap-weighted index of US biotechnology and pharmaceutical companies listed on the NASDAQ. IBBQ was launched on Jun 11, 2021 and is managed by Invesco.